The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2020 | Next questions in the treatment and management of MPNs
Srdan Verstovsek, MD, PhD, of The University of Texas MD Anderson Cancer Center, Houston, TX, explores the next steps in the treatment and management of myeloproliferative neoplasms (MPNs), including focusing on prevention of disease progression, life extension, as well as improving quality of life in patients with MPNs. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
